02-10-2020
There is currently no generally accepted strategy for the clinical diagnosis of acute uncomplicated cystitis. This study evaluated the diagnostic value of recently proposed draft guidelines for the clinical diagnosis of this condition by the US FDA and EMA using the previously validated Acute Cystitis Symptom Score (ACSS).
02-10-2020
People with diabetes are more prone to UTIs due to immune system and bladder dysfunction than people without diabetes. In light of controversies regarding the incidence, clinical pattern and microbiology of UTIs in diabetes patients, this prospective study sought to compare these aspects of UTI in patients with and without diabetes.
02-10-2020
It is recommended to avoid fluoroquinolones as first-line treatment for uncomplicated cystitis due to the risk of serious side effects but their use in this setting is still widespread. This study evaluated the extent and appropriateness of empiric fluoroquinolone use for uncomplicated cystitis compared with that of nitrofurantoin and identified predictors of empiric fluoroquinolone use for this indication.
02-10-2020
UTI is a common infection in children but can be a challenge to diagnose. In addition, controversies exist regarding its investigation and management and recommendations vary across guidelines. This review paper gives an overview of these aspects with highlights from recent evidence and guideline recommendations.
22-09-2020
The burden of community-acquired pneumonia (CAP) is set to increase with ageing populations and with it the need for appropriate antibiotic prescribing in the face of increasing bacterial resistance. This review provides an update on the epidemiology of bacterial CAP and the patterns of antibiotic resistance around the world.
22-09-2020
Patient health literacy is an important factor that impacts antimicrobial stewardship (AMS) in the community. Using a Centers for Disease Control and Prevention (CDC) framework, the authors of this paper describe four core elements for enhancing AMS health literacy in the outpatient setting.
22-09-2020
Serious bacterial infections (SBIs) occur more frequently in infants aged ≤90 days than in other paediatric groups and are increasingly due to multi-drug-resistant organisms (MDROs). This study assessed the epidemiology and bacteriology of SBIs in early infancy and compared the characteristics and outcomes of infections due to MDROs versus non-MDROs.
22-09-2020
Overuse of antibiotics for respiratory tract infection (RTI) and urinary tract infection (UTI) is widespread in primary care and long-term care settings, respectively. This paper describes the Using Antibiotics Wisely campaign that sought to boost antimicrobial stewardship among community prescribers in Canada. Prescribers were enlisted to develop practice change statements to support the appropriate use of antibiotics for RTIs and UTIs in the community.
16-01-2018
Who we are: our mission and global narrative story
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b vaccine (adsorbed) <br>Vaccines
Abacavir / Lamivudina<br> VIH
Abacavir sulfate-lamivudine<br> HIV
Lamotrigine<br> Central Nervous System
Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b vaccine (adsorbed) <br>Vaccines
Furoato de fluticasona<br> Respiratorio
Fluticasone furoate<br> Respiratory
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed<br> Vaccines
Clobetasol propionate<br> Dermatology
Cefuroxime axetil</br>Anti-infective
Betamethasone valerate<br> Dermatology
Furoato de fluticasone / vilanterol<br> Respiratorio
Fluticasone furoate/vilanterol<br> Respiratory
Dutasterida/Tamsulosina<br> Urología
Dutasteride/Tamsulosin HCI<br> Urology
Paroxetine<br> Central Nervous System
Cetirizine dihydrochloride</br>Respiratory
Salmeterol/Propionato de fluticasona<br> Respiratorio
Salmeterol/fluticasone propionate<br> Respiratory
Pneumococcal polysaccharide conjugate vaccine (adsorbed)<br> Vaccines
Levetiracetam<br> Central Nervous System
Albendazole</br>Gastroenterology
Amoxicillin/ Clavulanic Acid<br> Anti-infectives
Vacunacontra rotavirus<br> Vacunas
Oral rotavirus vaccine<br> Vaccines
GlaxoSmithKline (GSK) UK healthcare professional website site map.
GlaxoSmithKline (GSK) UK healthcare professional website search results.
Paroxetine <br> Central Nervous System
Varicella vaccine</br>Vaccines
Measles, mumps and rubella vaccine</br>Vaccines
Inactivated hepatitis A and rDNA hepatitis B vaccine (adsorbed)</br>Vaccines
Hepatitis B (rDNA) vaccine (adsorbed) </br>Vaccines
Inactivated hepatitis A vaccine</br>Vaccines
Cookie information for users
Zoster vaccine recombinant, adjuvanted<br> Vaccine
Zoster vaccine recombinant, adjuvanted<br>Vaccine
amoxicillin-clavulanate<br>Anti infectives
amoxicillin-clavulanate<br>Anti infectives
Amoxicilina/ Ácido Clavulánico<br> Antiinfecciosos
Vacuna combinada de difteria, tétanos y tosferina acelular Para niños y adultos<br> Vacunas
Salmeterol/Propionato de fluticasona<br> Respiratorio
Mupirocin<br> Dermatology
Propionato de Fluticasona<br> Dermatología
Propionato de Fluticasona<br> Respiratorio
Salbutamol<br> Respiratory
Fluticasone Propionate<br> Respiratory
Fluticasone propionate<br> Dermatology
Umeclidinium/Vilanterol<br> Respiratory
Umeclidinio/Vilanterol<br> Respiratorio
Salbutamo </br> Respiratorio
Salbutamo<br> Respiratorio
Salbutamol<br> Respiratory
Salbutamol</br> Respiratory
Valerato de Betametasona<br> Dermatología
Zoster vaccine recombinant, adjuvanted<br>Vaccine
Propionato de Fluticasona <br> Dermatología
Propionato de Clobetasol <br> Dermatología
Clobetasol propionate<br> Dermatology
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) product information and resources to support HCPs in their daily practice.
Shingrix (Zoster Vaccine Recombinant, Adjuvanted) What is the Risk of Shingles
The safety of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) was extensively studied in 2 large phase 3 clinical trials
SHINGRIX in your Practice
Is SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) right for your patients? Nearly everyone ≥50 years old needs shingles protection
Recommend the shingles vaccine specifically formulated to address age-related decline in immunity
Shingrix (Zoster Vaccine Recombinant, Adjuvanted) Data showing the Efficacy of Shingrix Against Shingles
SHINGRIX information for UK healthcare professionals only
Read about SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) dosing and administration details, information to share with patients, and guidance for series completion
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) is recommended by the CDC for the prevention of shingles (herpes zoster) and related complications for immunocompetent adults aged ≥50 years.